Lataa...
Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
During malignant transformation, a growing body of mutations accumulate in cancer cells which not only drive cancer progression but also endow cancer cells with high immunogenicity. However, because one or multiple steps in cancer-immunity cycle are impaired, anti-cancer immune response is too weak...
Tallennettuna:
| Julkaisussa: | Onco Targets Ther |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6857659/ https://ncbi.nlm.nih.gov/pubmed/31807028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S224013 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|